Private Market View

Solugen

Multi-line Chemicals

Last price · $/share
Implied valuation
Total raised
$357.0M
Last round
Later Stage VC (Series C1)
Nov 2021
Valuation — not yet established

No valuation for Solugen is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($357.0M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
  • ·Post-money valuations for all 4 rounds
  • ·Watchlist + deal alerts for Solugen
Create free account
No card required

Funding history

4 rounds
DateRoundRaisedPost-money
Nov 2021Later Stage VC (Series C1)$357.0M
Mar 2020Early Stage VC$30.1M
Apr 2019Early Stage VC$20.0M
Oct 2018Early Stage VC$18.8M

How Solugen's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Solugen, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

How much has Solugen raised?
Solugen has raised $357.0M in total funding across 4 recorded rounds.
When did Solugen last raise?
Solugen last raised in Nov 2021 (Later Stage VC (Series C1)), raising $357.0M.